Serum Glial Fibrillary Acidic Protein (sGFAP) as potential biomarker for cognition and neuropsychiatric symptoms in multiple sclerosis?

被引：0

作者：

Koelsche, Tristan ^{[1
,2
]}

Renner, Alina ^{[3
]}

Aktas, Orhan ^{[1
,2
]}

Baetge, Sharon ^{[3
]}

Filser, Melanie ^{[3
,4
]}

Albrecht, Philipp ^{[5
]}

Steffen, Falk ^{[6
]}

Bittner, Stefan ^{[6
]}

Meuth, Sven ^{[1
,2
]}

Pawlitzki, Marc ^{[1
,2
]}

Penner, Iris-Katharina ^{[3
,7
]}

机构：

[1] Heinrich Heine Univ, Dept Neurol, Med Fac, Dusseldorf, Germany

[2] Heinrich Heine Univ, Univ Hosp Duesseldorf, Dept Neurol, Dusseldorf, Germany

[3] Cogito Ctr Appl Neurocognit & Neuropsychol Res, Dusseldorf, Germany

[4] Heinrich Heine Univ, Dept Expt Psychol, Dusseldorf, Germany

[5] Maria Hilf Clin Moenchengladbach, Dept Neurol, Monchengladbach, Germany

[6] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci FTN & Immunothera, Rhine Main Neurosci Network Rmn2,Dept Neurol, Mainz, Germany

[7] Univ Bern, Bern Univ Hosp, Dept Neurol, Inselspital, Bern, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1529/1400

引用

页码：970 / 971

页数：2

共 50 条

[1] Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
Axelsson, M.
Malmestrom, C.
Nilsson, S.
Haghighi, S.
Rosengren, L.
Lycke, J.
JOURNAL OF NEUROLOGY, 2011, 258 (05) : 882 - 888
[2] Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
M. Axelsson
C. Malmeström
S. Nilsson
S. Haghighi
L. Rosengren
J. Lycke
Journal of Neurology, 2011, 258 : 882 - 888
[3] Serum Glial Fibrillary Acidic Protein: A Biomarker of Disease Progression in Multiple Sclerosis
Barro, C.
Healy, B.
Liu, Y.
Saxena, S.
Paul, A.
Polgar-Turcsanyi, M.
Guttmann, C.
Bakshi, R.
Kropshofer, H.
Weiner, H.
Chitnis, T.
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 154 - 154
[4] Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
Hogel, Heidi
Rissanen, Eero
Barro, Christian
Matilainen, Markus
Nylund, Marjo
Kuhle, Jens
Airas, Laura
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (02) : 210 - 219
[5] Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
Abdelhak, Ahmed
Antweiler, Kai
Kowarik, Markus C.
Senel, Makbule
Havla, Joachim
Zettl, Uwe K.
Kleiter, Ingo
Skripuletz, Thomas
Haarmann, Axel
Stahmann, Alexander
Huss, Andre
Gingele, Stefan
Krumbholz, Markus
Benkert, Pascal
Kuhle, Jens
Friede, Tim
Ludolph, Albert C.
Ziemann, Ulf
Kuempfel, Tania
Tumani, Hayrettin
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (02): : 477 - 485
[6] Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis
Madill, Evan
Healy, Brian C.
Molazadeh, Negar
Polgar-Turcsanyi, Mariann
Glanz, Bonnie I.
Weiner, Howard L.
Chitnis, Tanuja
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (10): : 2719 - 2730
[7] Neurofilament and glial fibrillary acidic protein in multiple sclerosis
Norgren, N
Sundström, P
Svenningsson, A
Rosengren, L
Stigbrand, T
Gunnarsson, M
NEUROLOGY, 2004, 63 (09) : 1586 - 1590
[8] Serum glial fibrillary acidic protein compared with neurofilament light chain as biomarker for multiple sclerosis disease progression
Meier, S.
Benkert, P.
Maceski, A.
Schaedelin, S.
Garcia, L. Melie
Cagol, A.
Barakovic, M.
Galbusera, R.
Subramaniam, S.
Achtnichts, L.
Lalive, P. H.
Bridel, C.
Muller, S.
Pot, C.
Salmen, A.
Disanto, G.
Zecca, C.
Orleth, A.
Khalil, M.
Yaldizli, O.
Oechtering, J.
Battaglini, M.
Kappos, L.
Derfuss, T.
Leppert, D.
Gobbi, C.
Granziera, C.
Willemse, E. A. J.
Kuhle, J.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 122 - 123
[9] Serum glial fibrillary acidic protein (sGFAP) levels are reduced by fingolimod treatment and prognosticate disease progression independent of relapse activity in multiple sclerosis
Maceski, Aleksandra Maleska
Benkert, Pascal
Oechtering, Johanna
Schadelin, Sabine
Zadic, Amar
Gomez, Juan Francisco Vilchez
Melie-Garcia, Lester
Cagol, Alessandro
Galbusera, Riccardo
Subramaniam, Suvitha
Lorscheider, Johannes
Fischer-Barnicol, Bettina
Achtnichts, Lutz
Findling, Oliver
Lalive, Patrice
Uginet, Marjolaine
Mueller, Stefanie
Pot, Caroline
Mathias, Amandine
Du Pasquier, Renaud
Hoepner, Robert
Chan, Andrew
Disanto, Giulio
Zecca, Chiara
Conen, David
Buser, Andreas
DSouza, Marcus
Yaldizli, Ozgur
Derfuss, Tobias
Gobbi, Claudio
Khalil, Michael
Brassat, David
Janiaud, Perrine Marine Charlotte
Hemkens, Lars
Oksenberg, Jorge R.
Wiendl, Heinz
Berger, Klaus
Hermesdorf, Marco
Piehl, Fredrik
Kappos, Ludwig
Abdelhak, Ahmed
Granziera, Cristina
Willemse, Eline
Leppert, David
Kuhle, Jens
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 56 - 58
[10] Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
Meier, Stephanie
Willemse, Eline A. J.
Schaedelin, Sabine
Oechtering, Johanna
Lorscheider, Johannes
Melie-Garcia, Lester
Cagol, Alessandro
Barakovic, Muhamed
Galbusera, Riccardo
Subramaniam, Suvitha
Barro, Christian
Abdelhak, Ahmed
Thebault, Simon
Achtnichts, Lutz
Lalive, Patrice
Muller, Stefanie
Pot, Caroline
Salmen, Anke
Disanto, Giulio
Zecca, Chiara
D'Souza, Marcus
Orleth, Annette
Khalil, Michael
Buchmann, Arabella
Du Pasquier, Renaud
Yaldizli, Ozgur
Derfuss, Tobias
Berger, Klaus
Hermesdorf, Marco
Wiendl, Heinz
Piehl, Fredrik
Battaglini, Marco
Fischer, Urs
Kappos, Ludwig
Gobbi, Claudio
Granziera, Cristina
Bridel, Claire
Leppert, David
Maceski, Aleksandra Maleska
Benkert, Pascal
Kuhle, Jens
JAMA NEUROLOGY, 2023, 80 (03) : 287 - 297

← 1 2 3 4 5 →